Edition:
United Kingdom

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

3.81USD
15 Feb 2019
Change (% chg)

$0.31 (+8.86%)
Prev Close
$3.50
Open
$3.53
Day's High
$3.90
Day's Low
$3.47
Volume
84,416
Avg. Vol
111,379
52-wk High
$8.05
52-wk Low
$2.62

Chart for

About

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related... (more)

Overall

Beta: --
Market Cap(Mil.): $153.67
Shares Outstanding(Mil.): 43.29
Dividend: --
Yield (%): --

Financials

  ADVM.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.53 -- --
ROI: -28.12 8.92 14.45
ROE: -29.20 10.08 15.96

Earnings vs. Estimates